Historical Development and Administration of Valproic Acid

565 Words2 Pages

Historical Development

Valproic acid has an analogue found in nature in the form of the valerian plant. This chemical was artificially synthesized in 1882 using the chemical in valerian as a reference. The chemical is a liquid at room temperature and was and was for a long time employed as a chemically inert solvent. Application for the drug was discovered as an anticonvulsant and antiepileptic drug in 1962 by the French researcher Pierre Eymard while he was comparing different compound for antisezure properties. Valproic acid was approved as a antiepileptic drug in 1967 and has sense become a very widely used drug in the area epileptic reduction. Other, later discovered application for the drug, include migraine, bipolar disorder, and major depression. Valproic acid may also have a market in HIV, cancer, stem cell research, but current research is being conducted.

Compound’s Mechanism of Action

As a treatment of bipolar disorder, the mechanism of valproic acid is not completely understood, but the mechanism of valproic acid is thought to affect the neurotransmission of gamma-Aminobutyric acid (GABA) in the brain. The specific mechanism is thought of a GABA neutransmitter inhibitor, which inhibits GABA transaminase and subsequently increases the concentration of GABA. This mechanism is comparable to lithium salts for bipolar disorder.

As an anticonvulsant, valproic acid blocks the voltage sodium and calcium channels, which form the barrier of the cells plasma membrane. The cationic channels act by allowing the ions of chemicals to pass through the semipermiable membrane of the cells and generate subsequent reactions. The goal of any anticonvulsant is the reduction of excess neural particles that rapidly fire during a seizur...

... middle of paper ...

... Chemical Research in Toxicology 9 (2), 517-526.

Lauri Peura, Kalle Malmioja, Krista Laine, Jukka Leppnen, Mikko Gynther, Antti Isotalo, Jarkko Rautio (2011). Large Amino Acid Transporter 1 (LAT1) Prodrugs of Valproic Acid: New Prodrug Design Ideas for Central Nervous System Delivery. Molecular Pharmaceutics Article ASAP.

Jianxun Li, Daniel L. Norwood. (1990). Mitochondrial Metabolism of Valproic Acid. Biochemistry 30, 388-394.

Nieves C. Comelli, Rosana M. Lobayan, Eduardo A. Castro, Alicia H. Jubert. (2011). Study of the Structural and Electronic Properties of Valproic Acid and New Derivatives Used As Anticonvulsant Agents. The Journal of Physical Chemistry 115 (9), 1686-1700

Ali R. Tabatabaei and, Frank S. Abbott. (1999). Assessing the Mechanism of Metabolism-Dependent Valproic Acid-Induced in Vitro Cytotoxicity. Chemical Research in Toxicology 12 (4), 323-330

More about Historical Development and Administration of Valproic Acid

Open Document